Printable Organic Semiconducting Materials and Formulations - Combining High Performance and Air Stability

Mark James received a BSc from Durham and a PhD from Newcastle-upon-Tyne, specializing in organic synthesis. After postdoctoral research at Southampton, he joined ICI and remained there for 18 years seeing the transformation through Zeneca to Avecia InkJet Limited. For 10 years he ran IJ projects ranging from colorant design to developing industrials processes to manufacture PCBs. In 2005 he moved to the Centre for Process Innovation to set up and manage their flexible electronics substrate research and manufacturing operation. Returning to IJ in 2006, Mark now leads Merck's IJ activities covering topics including OLED, OSC and PV patterning.

Merck is a global pharmaceutical and chemical enterprise. Its success is characterized by innovations from entrepreneurial employees. The pharmaceuticals business sector comprises innovative prescription drugs, e.g. for the treatment of cancer, neurodegenerative diseases and growth disorders, cardiovascular diseases and infertility. Added to this are consumer health care

products. The Chemicals business sector offers chemicals for sophisticated applications: liquid crystals for displays, effect pigments for industry and cosmetics, analytical reagents and test kits, as well as products and services along the entire process chain of the pharmaceutical and biotech industries.

Merck is the world's oldest pharmaceutical and chemical company - its roots date back to 1668. With more than 60 sites around the world, Merck is at home in nearly all industrial countries. The development and commercialisation of printable organic materials and formulations for emerging displays and electronics applications and markets is based at Merck's Advanced Technologies - Chilworth (AT-C) Technical Centre, Southampton, UK.